Literature DB >> 20162354

Impedance in isolated mouse lungs for the determination of site of action of vasoactive agents and disease.

Rebecca R Vanderpool1, Robert Naeije, Naomi C Chesler.   

Abstract

Hypoxic pulmonary hypertension is a disease of the lung vasculature that is usually quantified by pulmonary vascular resistance (PVR). However, a more complete description of lung vascular function and right ventricular afterload is provided by pulmonary vascular impedance (PVZ) from spectral analysis of pulsatile pressure-flow relationships. We studied pulsatile pressure-flow relationships in isolated, perfused lungs of mice in normoxia, after induction of hypoxic pulmonary hypertension by 10 days of hypoxic exposure, and after the administration of the vasoactive agents sodium nitroprusside and serotonin in order to gain insight into the effects of disease and vasoactive agents on afterload. Chronic hypoxia exposure increased 0 Hz impedance (Z(0)) from 2.0 +/- 0.2 to 3.3 +/- 0.2 mmHg min/mL but decreased characteristic impedance (Z(C)) from 0.21 +/- 0.02 to 0.18 +/- 0.01 mmHg min/mL (both p < 0.05). Sodium nitroprusside only slightly decreased Z(0) but increased Z(C) in normal lungs (p < 0.05) and did not affect Z(C) and decreased Z(0) in hypertensive lungs (p < 0.05). Serotonin increased Z(C) in normal and hypertensive lungs but decreased Z(0) in hypertensive lungs (p < 0.05). There was an inverse correlation between mean pulmonary artery pressure and Z(C) in all circumstances. These findings demonstrate that vasoactive interventions can have different sites of action (i.e., proximal vs. distal segments) in the normal and chronically hypoxic pulmonary vasculature, and the pressure-dependency of Z(C) and R(W). The measurement of PVZ in isolated lungs allows for an improved understanding of the modes of action of drugs and hypoxia on the pulmonary circulation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20162354      PMCID: PMC2997745          DOI: 10.1007/s10439-010-9960-2

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   3.934


  22 in total

1.  Pulmonary vascular remodeling in isolated mouse lungs: effects on pulsatile pressure-flow relationships.

Authors:  Holly A Tuchscherer; Rebecca R Vanderpool; Naomi C Chesler
Journal:  J Biomech       Date:  2006-06-06       Impact factor: 2.712

2.  Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure.

Authors:  Norbert F Voelkel; Robert A Quaife; Leslie A Leinwand; Robyn J Barst; Michael D McGoon; Daniel R Meldrum; Jocelyn Dupuis; Carlin S Long; Lewis J Rubin; Frank W Smart; Yuichiro J Suzuki; Mark Gladwin; Elizabeth M Denholm; Dorothy B Gail
Journal:  Circulation       Date:  2006-10-24       Impact factor: 29.690

3.  Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hypertension.

Authors:  Srijoy Mahapatra; Rick A Nishimura; Paul Sorajja; Stephen Cha; Michael D McGoon
Journal:  J Am Coll Cardiol       Date:  2006-01-26       Impact factor: 24.094

4.  Effects of sildenafil on hypoxic pulmonary vascular function in dogs.

Authors:  Pierre Fesler; Alberto Pagnamenta; Benoit Rondelet; François Kerbaul; Robert Naeije
Journal:  J Appl Physiol (1985)       Date:  2006-06-15

5.  Pulmonary vascular resistance and impedance in isolated mouse lungs: effects of pulmonary emboli.

Authors:  Holly A Tuchscherer; Eidan B Webster; Naomi C Chesler
Journal:  Ann Biomed Eng       Date:  2006-03-28       Impact factor: 3.934

6.  Long-term monitoring of pulmonary arterial pressure in conscious, unrestrained mice.

Authors:  Daryl O Schwenke; James T Pearson; Hidezo Mori; Mikiyasu Shirai
Journal:  J Pharmacol Toxicol Methods       Date:  2005-12-09       Impact factor: 1.950

7.  Noninvasively assessed pulmonary artery stiffness predicts mortality in pulmonary arterial hypertension.

Authors:  C Tji-Joong Gan; Jan-Willem Lankhaar; Nico Westerhof; J Tim Marcus; Annemarie Becker; Jos W R Twisk; Anco Boonstra; Pieter E Postmus; Anton Vonk-Noordegraaf
Journal:  Chest       Date:  2007-11-07       Impact factor: 9.410

8.  Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice.

Authors:  Lu Long; Margaret R MacLean; Trina K Jeffery; Ian Morecroft; Xudong Yang; Nung Rudarakanchana; Mark Southwood; Victoria James; Richard C Trembath; Nicholas W Morrell
Journal:  Circ Res       Date:  2006-02-23       Impact factor: 17.367

9.  Pulmonary vascular input impedance is a combined measure of pulmonary vascular resistance and stiffness and predicts clinical outcomes better than pulmonary vascular resistance alone in pediatric patients with pulmonary hypertension.

Authors:  Kendall S Hunter; Po-Feng Lee; Craig J Lanning; D Dunbar Ivy; K Scott Kirby; Lori R Claussen; K Chen Chan; Robin Shandas
Journal:  Am Heart J       Date:  2007-09-27       Impact factor: 4.749

Review 10.  A meta-analysis of randomized controlled trials in pulmonary arterial hypertension.

Authors:  Nazzareno Galiè; Alessandra Manes; Luca Negro; Massimiliano Palazzini; Maria Letizia Bacchi-Reggiani; Angelo Branzi
Journal:  Eur Heart J       Date:  2009-01-20       Impact factor: 29.983

View more
  12 in total

1.  Effects of acute Rho kinase inhibition on chronic hypoxia-induced changes in proximal and distal pulmonary arterial structure and function.

Authors:  Rebecca R Vanderpool; Ah Ram Kim; Robert Molthen; Naomi C Chesler
Journal:  J Appl Physiol (1985)       Date:  2010-11-18

2.  Patchy deletion of Bmpr1a potentiates proximal pulmonary artery remodeling in mice exposed to chronic hypoxia.

Authors:  Rebecca R Vanderpool; Nesrine El-Bizri; Marlene Rabinovitch; Naomi C Chesler
Journal:  Biomech Model Mechanobiol       Date:  2013-01

3.  What does the time constant of the pulmonary circulation tell us about the progression of right ventricular dysfunction in pulmonary arterial hypertension?

Authors:  A Bellofiore; Z Wang; N C Chesler
Journal:  Pulm Circ       Date:  2015-06       Impact factor: 3.017

4.  Pulmonary vascular mechanical consequences of ischemic heart failure and implications for right ventricular function.

Authors:  Jennifer L Philip; Thomas M Murphy; David A Schreier; Sydney Stevens; Diana M Tabima; Margie Albrecht; Andrea L Frump; Timothy A Hacker; Tim Lahm; Naomi C Chesler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-15       Impact factor: 4.733

5.  Pulmonary vascular collagen content, not cross-linking, contributes to right ventricular pulsatile afterload and overload in early pulmonary hypertension.

Authors:  Zhijie Wang; David A Schreier; Hinnah Abid; Timothy A Hacker; Naomi C Chesler
Journal:  J Appl Physiol (1985)       Date:  2016-11-17

6.  Characterization of the isolated, ventilated, and instrumented mouse lung perfused with pulsatile flow.

Authors:  Rebecca R Vanderpool; Naomi C Chesler
Journal:  J Vis Exp       Date:  2011-04-29       Impact factor: 1.355

7.  Measuring right ventricular function in the normal and hypertensive mouse hearts using admittance-derived pressure-volume loops.

Authors:  Diana M Tabima; Timothy A Hacker; Naomi C Chesler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-08       Impact factor: 4.733

8.  Impact of increased hematocrit on right ventricular afterload in response to chronic hypoxia.

Authors:  David A Schreier; Timothy A Hacker; Kendall Hunter; Jens Eickoff; Aiping Liu; Gouqing Song; Naomi Chesler
Journal:  J Appl Physiol (1985)       Date:  2014-08-28

Review 9.  Pulmonary circulation at exercise.

Authors:  Robert Naeije; N Chesler
Journal:  Compr Physiol       Date:  2012-01       Impact factor: 9.090

Review 10.  Pulmonary vascular mechanics: important contributors to the increased right ventricular afterload of pulmonary hypertension.

Authors:  Zhijie Wang; Naomi C Chesler
Journal:  Exp Physiol       Date:  2013-05-10       Impact factor: 2.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.